Dataset Viewer
Auto-converted to Parquet Duplicate
sample_id
stringlengths
11
11
clinical_text
stringlengths
18
347
category
stringclasses
5 values
subcategory
stringclasses
20 values
difficulty
stringclasses
4 values
drug_mentions
listlengths
1
14
regimen_mentions
listlengths
0
2
num_drugs
int64
1
8
note_type
stringclasses
10 values
ONCORX-0001
The patient was started on Abemaciclib.
C1_CORE_MED_EXTRACTION
C1.1_single_drug_simple
Easy
[ { "drug_surface": "Abemaciclib", "drug_normalized": "Abemaciclib", "status": "current", "negated": false, "allergy": false, "uncertain": false, "evidence_type": "explicit_surface", "start_char": 27, "end_char": 38 } ]
[]
1
progress_note
ONCORX-0002
Per oncology, continue Pembrolizumab.
C1_CORE_MED_EXTRACTION
C1.1_single_drug_simple
Easy
[ { "drug_surface": "Pembrolizumab", "drug_normalized": "Pembrolizumab", "status": "current", "negated": false, "allergy": false, "uncertain": false, "evidence_type": "explicit_surface", "start_char": 23, "end_char": 36 } ]
[]
1
progress_note
ONCORX-0003
Recommend initiation of Chlorambucil.
C1_CORE_MED_EXTRACTION
C1.1_single_drug_simple
Easy
[ { "drug_surface": "Chlorambucil", "drug_normalized": "Chlorambucil", "status": "current", "negated": false, "allergy": false, "uncertain": false, "evidence_type": "explicit_surface", "start_char": 24, "end_char": 36 } ]
[]
1
treatment_plan
ONCORX-0004
Current therapy: Capecitabine.
C1_CORE_MED_EXTRACTION
C1.1_single_drug_simple
Easy
[ { "drug_surface": "Capecitabine", "drug_normalized": "Capecitabine", "status": "current", "negated": false, "allergy": false, "uncertain": false, "evidence_type": "explicit_surface", "start_char": 17, "end_char": 29 } ]
[]
1
treatment_plan
ONCORX-0006
Treatment: Niraparib.
C1_CORE_MED_EXTRACTION
C1.1_single_drug_simple
Easy
[ { "drug_surface": "Niraparib", "drug_normalized": "Niraparib", "status": "current", "negated": false, "allergy": false, "uncertain": false, "evidence_type": "explicit_surface", "start_char": 11, "end_char": 20 } ]
[]
1
progress_note
ONCORX-0008
Oncology recommends Carmustine.
C1_CORE_MED_EXTRACTION
C1.1_single_drug_simple
Easy
[ { "drug_surface": "Carmustine", "drug_normalized": "Carmustine", "status": "current", "negated": false, "allergy": false, "uncertain": false, "evidence_type": "explicit_surface", "start_char": 20, "end_char": 30 } ]
[]
1
treatment_plan
ONCORX-0010
Home medications include Leuprolide.
C1_CORE_MED_EXTRACTION
C1.1_single_drug_simple
Easy
[ { "drug_surface": "Leuprolide", "drug_normalized": "Leuprolide", "status": "current", "negated": false, "allergy": false, "uncertain": false, "evidence_type": "explicit_surface", "start_char": 25, "end_char": 35 } ]
[]
1
treatment_plan
ONCORX-0011
Treatment: Ixazomib.
C1_CORE_MED_EXTRACTION
C1.1_single_drug_simple
Easy
[ { "drug_surface": "Ixazomib", "drug_normalized": "Ixazomib", "status": "current", "negated": false, "allergy": false, "uncertain": false, "evidence_type": "explicit_surface", "start_char": 11, "end_char": 19 } ]
[]
1
progress_note
ONCORX-0012
Please continue Sunitinib.
C1_CORE_MED_EXTRACTION
C1.1_single_drug_simple
Easy
[ { "drug_surface": "Sunitinib", "drug_normalized": "Sunitinib", "status": "current", "negated": false, "allergy": false, "uncertain": false, "evidence_type": "explicit_surface", "start_char": 16, "end_char": 25 } ]
[]
1
oncology_consult
ONCORX-0013
Currently maintained on Trastuzumab.
C1_CORE_MED_EXTRACTION
C1.1_single_drug_simple
Easy
[ { "drug_surface": "Trastuzumab", "drug_normalized": "Trastuzumab", "status": "current", "negated": false, "allergy": false, "uncertain": false, "evidence_type": "explicit_surface", "start_char": 24, "end_char": 35 } ]
[]
1
progress_note
ONCORX-0014
Initiate therapy with Durvalumab as discussed.
C1_CORE_MED_EXTRACTION
C1.1_single_drug_simple
Easy
[ { "drug_surface": "Durvalumab", "drug_normalized": "Durvalumab", "status": "current", "negated": false, "allergy": false, "uncertain": false, "evidence_type": "explicit_surface", "start_char": 22, "end_char": 32 } ]
[]
1
progress_note
ONCORX-0015
Treatment: Exemestane.
C1_CORE_MED_EXTRACTION
C1.1_single_drug_simple
Easy
[ { "drug_surface": "Exemestane", "drug_normalized": "Exemestane", "status": "current", "negated": false, "allergy": false, "uncertain": false, "evidence_type": "explicit_surface", "start_char": 11, "end_char": 21 } ]
[]
1
oncology_consult
ONCORX-0016
Recommend initiation of Mercaptopurine.
C1_CORE_MED_EXTRACTION
C1.1_single_drug_simple
Easy
[ { "drug_surface": "Mercaptopurine", "drug_normalized": "Mercaptopurine", "status": "current", "negated": false, "allergy": false, "uncertain": false, "evidence_type": "explicit_surface", "start_char": 24, "end_char": 38 } ]
[]
1
progress_note
ONCORX-0017
Assessment/Plan: Durvalumab for treatment.
C1_CORE_MED_EXTRACTION
C1.1_single_drug_simple
Easy
[ { "drug_surface": "Durvalumab", "drug_normalized": "Durvalumab", "status": "current", "negated": false, "allergy": false, "uncertain": false, "evidence_type": "explicit_surface", "start_char": 17, "end_char": 27 } ]
[]
1
progress_note
ONCORX-0018
Pt currently receiving Bendamustine.
C1_CORE_MED_EXTRACTION
C1.1_single_drug_simple
Easy
[ { "drug_surface": "Bendamustine", "drug_normalized": "Bendamustine", "status": "current", "negated": false, "allergy": false, "uncertain": false, "evidence_type": "explicit_surface", "start_char": 23, "end_char": 35 } ]
[]
1
progress_note
ONCORX-0019
Currently maintained on Gefitinib.
C1_CORE_MED_EXTRACTION
C1.1_single_drug_simple
Easy
[ { "drug_surface": "Gefitinib", "drug_normalized": "Gefitinib", "status": "current", "negated": false, "allergy": false, "uncertain": false, "evidence_type": "explicit_surface", "start_char": 24, "end_char": 33 } ]
[]
1
oncology_consult
ONCORX-0020
Per oncology, continue Everolimus.
C1_CORE_MED_EXTRACTION
C1.1_single_drug_simple
Easy
[ { "drug_surface": "Everolimus", "drug_normalized": "Everolimus", "status": "current", "negated": false, "allergy": false, "uncertain": false, "evidence_type": "explicit_surface", "start_char": 23, "end_char": 33 } ]
[]
1
progress_note
ONCORX-0021
Medications: Degarelix.
C1_CORE_MED_EXTRACTION
C1.1_single_drug_simple
Easy
[ { "drug_surface": "Degarelix", "drug_normalized": "Degarelix", "status": "current", "negated": false, "allergy": false, "uncertain": false, "evidence_type": "explicit_surface", "start_char": 13, "end_char": 22 } ]
[]
1
treatment_plan
ONCORX-0022
The patient is scheduled to receive Cytarabine.
C1_CORE_MED_EXTRACTION
C1.1_single_drug_simple
Easy
[ { "drug_surface": "Cytarabine", "drug_normalized": "Cytarabine", "status": "current", "negated": false, "allergy": false, "uncertain": false, "evidence_type": "explicit_surface", "start_char": 36, "end_char": 46 } ]
[]
1
oncology_consult
ONCORX-0024
Home medications include Ramucirumab.
C1_CORE_MED_EXTRACTION
C1.1_single_drug_simple
Easy
[ { "drug_surface": "Ramucirumab", "drug_normalized": "Ramucirumab", "status": "current", "negated": false, "allergy": false, "uncertain": false, "evidence_type": "explicit_surface", "start_char": 25, "end_char": 36 } ]
[]
1
treatment_plan
ONCORX-0025
Currently maintained on Dexamethasone.
C1_CORE_MED_EXTRACTION
C1.1_single_drug_simple
Easy
[ { "drug_surface": "Dexamethasone", "drug_normalized": "Dexamethasone", "status": "current", "negated": false, "allergy": false, "uncertain": false, "evidence_type": "explicit_surface", "start_char": 24, "end_char": 37 } ]
[]
1
oncology_consult
ONCORX-0027
Continue Idarubicin as previously prescribed.
C1_CORE_MED_EXTRACTION
C1.1_single_drug_simple
Easy
[ { "drug_surface": "Idarubicin", "drug_normalized": "Idarubicin", "status": "current", "negated": false, "allergy": false, "uncertain": false, "evidence_type": "explicit_surface", "start_char": 9, "end_char": 19 } ]
[]
1
treatment_plan
ONCORX-0028
Resume Carmustine after hold period.
C1_CORE_MED_EXTRACTION
C1.1_single_drug_simple
Easy
[ { "drug_surface": "Carmustine", "drug_normalized": "Carmustine", "status": "current", "negated": false, "allergy": false, "uncertain": false, "evidence_type": "explicit_surface", "start_char": 7, "end_char": 17 } ]
[]
1
oncology_consult
ONCORX-0029
Currently maintained on Ifosfamide.
C1_CORE_MED_EXTRACTION
C1.1_single_drug_simple
Easy
[ { "drug_surface": "Ifosfamide", "drug_normalized": "Ifosfamide", "status": "current", "negated": false, "allergy": false, "uncertain": false, "evidence_type": "explicit_surface", "start_char": 24, "end_char": 34 } ]
[]
1
progress_note
ONCORX-0030
The patient was started on Elotuzumab.
C1_CORE_MED_EXTRACTION
C1.1_single_drug_simple
Easy
[ { "drug_surface": "Elotuzumab", "drug_normalized": "Elotuzumab", "status": "current", "negated": false, "allergy": false, "uncertain": false, "evidence_type": "explicit_surface", "start_char": 27, "end_char": 37 } ]
[]
1
oncology_consult
ONCORX-0031
Medications: Mercaptopurine.
C1_CORE_MED_EXTRACTION
C1.1_single_drug_simple
Easy
[ { "drug_surface": "Mercaptopurine", "drug_normalized": "Mercaptopurine", "status": "current", "negated": false, "allergy": false, "uncertain": false, "evidence_type": "explicit_surface", "start_char": 13, "end_char": 27 } ]
[]
1
treatment_plan
ONCORX-0032
Patient seen in clinic today, currently on Ramucirumab.
C1_CORE_MED_EXTRACTION
C1.1_single_drug_simple
Easy
[ { "drug_surface": "Ramucirumab", "drug_normalized": "Ramucirumab", "status": "current", "negated": false, "allergy": false, "uncertain": false, "evidence_type": "explicit_surface", "start_char": 43, "end_char": 54 } ]
[]
1
progress_note
ONCORX-0033
Patient seen in clinic today, currently on Osimertinib.
C1_CORE_MED_EXTRACTION
C1.1_single_drug_simple
Easy
[ { "drug_surface": "Osimertinib", "drug_normalized": "Osimertinib", "status": "current", "negated": false, "allergy": false, "uncertain": false, "evidence_type": "explicit_surface", "start_char": 43, "end_char": 54 } ]
[]
1
progress_note
ONCORX-0034
Per oncology, continue Darolutamide.
C1_CORE_MED_EXTRACTION
C1.1_single_drug_simple
Easy
[ { "drug_surface": "Darolutamide", "drug_normalized": "Darolutamide", "status": "current", "negated": false, "allergy": false, "uncertain": false, "evidence_type": "explicit_surface", "start_char": 23, "end_char": 35 } ]
[]
1
treatment_plan
ONCORX-0035
Current therapy: Pegfilgrastim.
C1_CORE_MED_EXTRACTION
C1.1_single_drug_simple
Easy
[ { "drug_surface": "Pegfilgrastim", "drug_normalized": "Pegfilgrastim", "status": "current", "negated": false, "allergy": false, "uncertain": false, "evidence_type": "explicit_surface", "start_char": 17, "end_char": 30 } ]
[]
1
treatment_plan
ONCORX-0036
Will proceed with Cyclophosphamide.
C1_CORE_MED_EXTRACTION
C1.1_single_drug_simple
Easy
[ { "drug_surface": "Cyclophosphamide", "drug_normalized": "Cyclophosphamide", "status": "current", "negated": false, "allergy": false, "uncertain": false, "evidence_type": "explicit_surface", "start_char": 18, "end_char": 34 } ]
[]
1
treatment_plan
ONCORX-0038
Dacarbazine was administered during today's visit.
C1_CORE_MED_EXTRACTION
C1.1_single_drug_simple
Easy
[ { "drug_surface": "Dacarbazine", "drug_normalized": "Dacarbazine", "status": "current", "negated": false, "allergy": false, "uncertain": false, "evidence_type": "explicit_surface", "start_char": 0, "end_char": 11 } ]
[]
1
oncology_consult
ONCORX-0039
Per oncology, continue Crizotinib.
C1_CORE_MED_EXTRACTION
C1.1_single_drug_simple
Easy
[ { "drug_surface": "Crizotinib", "drug_normalized": "Crizotinib", "status": "current", "negated": false, "allergy": false, "uncertain": false, "evidence_type": "explicit_surface", "start_char": 23, "end_char": 33 } ]
[]
1
treatment_plan
ONCORX-0041
Assessment/Plan: Letrozole for treatment.
C1_CORE_MED_EXTRACTION
C1.1_single_drug_simple
Easy
[ { "drug_surface": "Letrozole", "drug_normalized": "Letrozole", "status": "current", "negated": false, "allergy": false, "uncertain": false, "evidence_type": "explicit_surface", "start_char": 17, "end_char": 26 } ]
[]
1
progress_note
ONCORX-0043
Assessment/Plan: Trastuzumab for treatment.
C1_CORE_MED_EXTRACTION
C1.1_single_drug_simple
Easy
[ { "drug_surface": "Trastuzumab", "drug_normalized": "Trastuzumab", "status": "current", "negated": false, "allergy": false, "uncertain": false, "evidence_type": "explicit_surface", "start_char": 17, "end_char": 28 } ]
[]
1
oncology_consult
ONCORX-0045
Please continue Azacitidine.
C1_CORE_MED_EXTRACTION
C1.1_single_drug_simple
Easy
[ { "drug_surface": "Azacitidine", "drug_normalized": "Azacitidine", "status": "current", "negated": false, "allergy": false, "uncertain": false, "evidence_type": "explicit_surface", "start_char": 16, "end_char": 27 } ]
[]
1
treatment_plan
ONCORX-0047
Pt currently receiving Acalabrutinib.
C1_CORE_MED_EXTRACTION
C1.1_single_drug_simple
Easy
[ { "drug_surface": "Acalabrutinib", "drug_normalized": "Acalabrutinib", "status": "current", "negated": false, "allergy": false, "uncertain": false, "evidence_type": "explicit_surface", "start_char": 23, "end_char": 36 } ]
[]
1
treatment_plan
ONCORX-0048
Recommend initiation of Pazopanib.
C1_CORE_MED_EXTRACTION
C1.1_single_drug_simple
Easy
[ { "drug_surface": "Pazopanib", "drug_normalized": "Pazopanib", "status": "current", "negated": false, "allergy": false, "uncertain": false, "evidence_type": "explicit_surface", "start_char": 24, "end_char": 33 } ]
[]
1
oncology_consult
ONCORX-0049
Patient reports taking Methotrexate at home.
C1_CORE_MED_EXTRACTION
C1.1_single_drug_simple
Easy
[ { "drug_surface": "Methotrexate", "drug_normalized": "Methotrexate", "status": "current", "negated": false, "allergy": false, "uncertain": false, "evidence_type": "explicit_surface", "start_char": 23, "end_char": 35 } ]
[]
1
treatment_plan
ONCORX-0051
Please continue Nivolumab.
C1_CORE_MED_EXTRACTION
C1.1_single_drug_simple
Easy
[ { "drug_surface": "Nivolumab", "drug_normalized": "Nivolumab", "status": "current", "negated": false, "allergy": false, "uncertain": false, "evidence_type": "explicit_surface", "start_char": 16, "end_char": 25 } ]
[]
1
oncology_consult
ONCORX-0052
Please continue Prednisone.
C1_CORE_MED_EXTRACTION
C1.1_single_drug_simple
Easy
[ { "drug_surface": "Prednisone", "drug_normalized": "Prednisone", "status": "current", "negated": false, "allergy": false, "uncertain": false, "evidence_type": "explicit_surface", "start_char": 16, "end_char": 26 } ]
[]
1
oncology_consult
ONCORX-0053
Patient reports taking Afatinib at home.
C1_CORE_MED_EXTRACTION
C1.1_single_drug_simple
Easy
[ { "drug_surface": "Afatinib", "drug_normalized": "Afatinib", "status": "current", "negated": false, "allergy": false, "uncertain": false, "evidence_type": "explicit_surface", "start_char": 23, "end_char": 31 } ]
[]
1
progress_note
ONCORX-0054
Venetoclax initiated per protocol.
C1_CORE_MED_EXTRACTION
C1.1_single_drug_simple
Easy
[ { "drug_surface": "Venetoclax", "drug_normalized": "Venetoclax", "status": "current", "negated": false, "allergy": false, "uncertain": false, "evidence_type": "explicit_surface", "start_char": 0, "end_char": 10 } ]
[]
1
progress_note
ONCORX-0055
Continue Atezolizumab as previously prescribed.
C1_CORE_MED_EXTRACTION
C1.1_single_drug_simple
Easy
[ { "drug_surface": "Atezolizumab", "drug_normalized": "Atezolizumab", "status": "current", "negated": false, "allergy": false, "uncertain": false, "evidence_type": "explicit_surface", "start_char": 9, "end_char": 21 } ]
[]
1
progress_note
ONCORX-0056
Home medications include Vinblastine.
C1_CORE_MED_EXTRACTION
C1.1_single_drug_simple
Easy
[ { "drug_surface": "Vinblastine", "drug_normalized": "Vinblastine", "status": "current", "negated": false, "allergy": false, "uncertain": false, "evidence_type": "explicit_surface", "start_char": 25, "end_char": 36 } ]
[]
1
progress_note
ONCORX-0057
Current therapy: Rituximab.
C1_CORE_MED_EXTRACTION
C1.1_single_drug_simple
Easy
[ { "drug_surface": "Rituximab", "drug_normalized": "Rituximab", "status": "current", "negated": false, "allergy": false, "uncertain": false, "evidence_type": "explicit_surface", "start_char": 17, "end_char": 26 } ]
[]
1
oncology_consult
ONCORX-0059
Will proceed with Crizotinib.
C1_CORE_MED_EXTRACTION
C1.1_single_drug_simple
Easy
[ { "drug_surface": "Crizotinib", "drug_normalized": "Crizotinib", "status": "current", "negated": false, "allergy": false, "uncertain": false, "evidence_type": "explicit_surface", "start_char": 18, "end_char": 28 } ]
[]
1
oncology_consult
ONCORX-0060
Per oncology, continue Bortezomib.
C1_CORE_MED_EXTRACTION
C1.1_single_drug_simple
Easy
[ { "drug_surface": "Bortezomib", "drug_normalized": "Bortezomib", "status": "current", "negated": false, "allergy": false, "uncertain": false, "evidence_type": "explicit_surface", "start_char": 23, "end_char": 33 } ]
[]
1
treatment_plan
ONCORX-0062
The patient was started on Goserelin.
C1_CORE_MED_EXTRACTION
C1.1_single_drug_simple
Easy
[ { "drug_surface": "Goserelin", "drug_normalized": "Goserelin", "status": "current", "negated": false, "allergy": false, "uncertain": false, "evidence_type": "explicit_surface", "start_char": 27, "end_char": 36 } ]
[]
1
treatment_plan
ONCORX-0064
Home medications include Avelumab.
C1_CORE_MED_EXTRACTION
C1.1_single_drug_simple
Easy
[ { "drug_surface": "Avelumab", "drug_normalized": "Avelumab", "status": "current", "negated": false, "allergy": false, "uncertain": false, "evidence_type": "explicit_surface", "start_char": 25, "end_char": 33 } ]
[]
1
oncology_consult
ONCORX-0065
Discussed starting Gemcitabine with the patient.
C1_CORE_MED_EXTRACTION
C1.1_single_drug_simple
Easy
[ { "drug_surface": "Gemcitabine", "drug_normalized": "Gemcitabine", "status": "current", "negated": false, "allergy": false, "uncertain": false, "evidence_type": "explicit_surface", "start_char": 19, "end_char": 30 } ]
[]
1
oncology_consult
ONCORX-0066
Medications: Vinorelbine.
C1_CORE_MED_EXTRACTION
C1.1_single_drug_simple
Easy
[ { "drug_surface": "Vinorelbine", "drug_normalized": "Vinorelbine", "status": "current", "negated": false, "allergy": false, "uncertain": false, "evidence_type": "explicit_surface", "start_char": 13, "end_char": 24 } ]
[]
1
progress_note
ONCORX-0068
Oncology recommends Procarbazine.
C1_CORE_MED_EXTRACTION
C1.1_single_drug_simple
Easy
[ { "drug_surface": "Procarbazine", "drug_normalized": "Procarbazine", "status": "current", "negated": false, "allergy": false, "uncertain": false, "evidence_type": "explicit_surface", "start_char": 20, "end_char": 32 } ]
[]
1
progress_note
ONCORX-0069
The patient is scheduled to receive Zanubrutinib.
C1_CORE_MED_EXTRACTION
C1.1_single_drug_simple
Easy
[ { "drug_surface": "Zanubrutinib", "drug_normalized": "Zanubrutinib", "status": "current", "negated": false, "allergy": false, "uncertain": false, "evidence_type": "explicit_surface", "start_char": 36, "end_char": 48 } ]
[]
1
progress_note
ONCORX-0070
Home medications include Brentuximab Vedotin.
C1_CORE_MED_EXTRACTION
C1.1_single_drug_simple
Easy
[ { "drug_surface": "Brentuximab Vedotin", "drug_normalized": "Brentuximab Vedotin", "status": "current", "negated": false, "allergy": false, "uncertain": false, "evidence_type": "explicit_surface", "start_char": 25, "end_char": 44 } ]
[]
1
oncology_consult
ONCORX-0071
Home medications include Cetuximab.
C1_CORE_MED_EXTRACTION
C1.1_single_drug_simple
Easy
[ { "drug_surface": "Cetuximab", "drug_normalized": "Cetuximab", "status": "current", "negated": false, "allergy": false, "uncertain": false, "evidence_type": "explicit_surface", "start_char": 25, "end_char": 34 } ]
[]
1
treatment_plan
ONCORX-0073
Resume Osimertinib after hold period.
C1_CORE_MED_EXTRACTION
C1.1_single_drug_simple
Easy
[ { "drug_surface": "Osimertinib", "drug_normalized": "Osimertinib", "status": "current", "negated": false, "allergy": false, "uncertain": false, "evidence_type": "explicit_surface", "start_char": 7, "end_char": 18 } ]
[]
1
progress_note
ONCORX-0074
Resume Ixazomib after hold period.
C1_CORE_MED_EXTRACTION
C1.1_single_drug_simple
Easy
[ { "drug_surface": "Ixazomib", "drug_normalized": "Ixazomib", "status": "current", "negated": false, "allergy": false, "uncertain": false, "evidence_type": "explicit_surface", "start_char": 7, "end_char": 15 } ]
[]
1
treatment_plan
ONCORX-0076
Dasatinib initiated per protocol.
C1_CORE_MED_EXTRACTION
C1.1_single_drug_simple
Easy
[ { "drug_surface": "Dasatinib", "drug_normalized": "Dasatinib", "status": "current", "negated": false, "allergy": false, "uncertain": false, "evidence_type": "explicit_surface", "start_char": 0, "end_char": 9 } ]
[]
1
progress_note
ONCORX-0077
The patient is scheduled to receive Gemcitabine.
C1_CORE_MED_EXTRACTION
C1.1_single_drug_simple
Easy
[ { "drug_surface": "Gemcitabine", "drug_normalized": "Gemcitabine", "status": "current", "negated": false, "allergy": false, "uncertain": false, "evidence_type": "explicit_surface", "start_char": 36, "end_char": 47 } ]
[]
1
oncology_consult
ONCORX-0079
Continue Lomustine as previously prescribed.
C1_CORE_MED_EXTRACTION
C1.1_single_drug_simple
Easy
[ { "drug_surface": "Lomustine", "drug_normalized": "Lomustine", "status": "current", "negated": false, "allergy": false, "uncertain": false, "evidence_type": "explicit_surface", "start_char": 9, "end_char": 18 } ]
[]
1
progress_note
ONCORX-0080
Please continue Polatuzumab Vedotin.
C1_CORE_MED_EXTRACTION
C1.1_single_drug_simple
Easy
[ { "drug_surface": "Polatuzumab Vedotin", "drug_normalized": "Polatuzumab Vedotin", "status": "current", "negated": false, "allergy": false, "uncertain": false, "evidence_type": "explicit_surface", "start_char": 16, "end_char": 35 } ]
[]
1
progress_note
ONCORX-0081
Patient has been on Ifosfamide since last visit.
C1_CORE_MED_EXTRACTION
C1.1_single_drug_simple
Easy
[ { "drug_surface": "Ifosfamide", "drug_normalized": "Ifosfamide", "status": "current", "negated": false, "allergy": false, "uncertain": false, "evidence_type": "explicit_surface", "start_char": 20, "end_char": 30 } ]
[]
1
oncology_consult
ONCORX-0083
Recommend initiation of Avelumab.
C1_CORE_MED_EXTRACTION
C1.1_single_drug_simple
Easy
[ { "drug_surface": "Avelumab", "drug_normalized": "Avelumab", "status": "current", "negated": false, "allergy": false, "uncertain": false, "evidence_type": "explicit_surface", "start_char": 24, "end_char": 32 } ]
[]
1
progress_note
ONCORX-0084
Apalutamide initiated per protocol.
C1_CORE_MED_EXTRACTION
C1.1_single_drug_simple
Easy
[ { "drug_surface": "Apalutamide", "drug_normalized": "Apalutamide", "status": "current", "negated": false, "allergy": false, "uncertain": false, "evidence_type": "explicit_surface", "start_char": 0, "end_char": 11 } ]
[]
1
treatment_plan
ONCORX-0085
Per oncology, continue Etoposide.
C1_CORE_MED_EXTRACTION
C1.1_single_drug_simple
Easy
[ { "drug_surface": "Etoposide", "drug_normalized": "Etoposide", "status": "current", "negated": false, "allergy": false, "uncertain": false, "evidence_type": "explicit_surface", "start_char": 23, "end_char": 32 } ]
[]
1
treatment_plan
ONCORX-0086
Will proceed with Brentuximab Vedotin.
C1_CORE_MED_EXTRACTION
C1.1_single_drug_simple
Easy
[ { "drug_surface": "Brentuximab Vedotin", "drug_normalized": "Brentuximab Vedotin", "status": "current", "negated": false, "allergy": false, "uncertain": false, "evidence_type": "explicit_surface", "start_char": 18, "end_char": 37 } ]
[]
1
oncology_consult
ONCORX-0087
The patient is scheduled to receive Busulfan.
C1_CORE_MED_EXTRACTION
C1.1_single_drug_simple
Easy
[ { "drug_surface": "Busulfan", "drug_normalized": "Busulfan", "status": "current", "negated": false, "allergy": false, "uncertain": false, "evidence_type": "explicit_surface", "start_char": 36, "end_char": 44 } ]
[]
1
treatment_plan
ONCORX-0088
Patient has been on Atezolizumab since last visit.
C1_CORE_MED_EXTRACTION
C1.1_single_drug_simple
Easy
[ { "drug_surface": "Atezolizumab", "drug_normalized": "Atezolizumab", "status": "current", "negated": false, "allergy": false, "uncertain": false, "evidence_type": "explicit_surface", "start_char": 20, "end_char": 32 } ]
[]
1
treatment_plan
ONCORX-0089
Active medication: Mitomycin.
C1_CORE_MED_EXTRACTION
C1.1_single_drug_simple
Easy
[ { "drug_surface": "Mitomycin", "drug_normalized": "Mitomycin", "status": "current", "negated": false, "allergy": false, "uncertain": false, "evidence_type": "explicit_surface", "start_char": 19, "end_char": 28 } ]
[]
1
oncology_consult
ONCORX-0090
Current therapy: Lorlatinib.
C1_CORE_MED_EXTRACTION
C1.1_single_drug_simple
Easy
[ { "drug_surface": "Lorlatinib", "drug_normalized": "Lorlatinib", "status": "current", "negated": false, "allergy": false, "uncertain": false, "evidence_type": "explicit_surface", "start_char": 17, "end_char": 27 } ]
[]
1
treatment_plan
ONCORX-0091
Medications: Osimertinib.
C1_CORE_MED_EXTRACTION
C1.1_single_drug_simple
Easy
[ { "drug_surface": "Osimertinib", "drug_normalized": "Osimertinib", "status": "current", "negated": false, "allergy": false, "uncertain": false, "evidence_type": "explicit_surface", "start_char": 13, "end_char": 24 } ]
[]
1
treatment_plan
ONCORX-0092
The patient was started on Sunitinib.
C1_CORE_MED_EXTRACTION
C1.1_single_drug_simple
Easy
[ { "drug_surface": "Sunitinib", "drug_normalized": "Sunitinib", "status": "current", "negated": false, "allergy": false, "uncertain": false, "evidence_type": "explicit_surface", "start_char": 27, "end_char": 36 } ]
[]
1
progress_note
ONCORX-0094
Please continue Oxaliplatin.
C1_CORE_MED_EXTRACTION
C1.1_single_drug_simple
Easy
[ { "drug_surface": "Oxaliplatin", "drug_normalized": "Oxaliplatin", "status": "current", "negated": false, "allergy": false, "uncertain": false, "evidence_type": "explicit_surface", "start_char": 16, "end_char": 27 } ]
[]
1
treatment_plan
ONCORX-0095
Please continue Carmustine.
C1_CORE_MED_EXTRACTION
C1.1_single_drug_simple
Easy
[ { "drug_surface": "Carmustine", "drug_normalized": "Carmustine", "status": "current", "negated": false, "allergy": false, "uncertain": false, "evidence_type": "explicit_surface", "start_char": 16, "end_char": 26 } ]
[]
1
progress_note
ONCORX-0097
Continue Ribociclib as previously prescribed.
C1_CORE_MED_EXTRACTION
C1.1_single_drug_simple
Easy
[ { "drug_surface": "Ribociclib", "drug_normalized": "Ribociclib", "status": "current", "negated": false, "allergy": false, "uncertain": false, "evidence_type": "explicit_surface", "start_char": 9, "end_char": 19 } ]
[]
1
progress_note
ONCORX-0099
Assessment/Plan: Elotuzumab for treatment.
C1_CORE_MED_EXTRACTION
C1.1_single_drug_simple
Easy
[ { "drug_surface": "Elotuzumab", "drug_normalized": "Elotuzumab", "status": "current", "negated": false, "allergy": false, "uncertain": false, "evidence_type": "explicit_surface", "start_char": 17, "end_char": 27 } ]
[]
1
progress_note
ONCORX-0100
Patient reports taking Venetoclax at home.
C1_CORE_MED_EXTRACTION
C1.1_single_drug_simple
Easy
[ { "drug_surface": "Venetoclax", "drug_normalized": "Venetoclax", "status": "current", "negated": false, "allergy": false, "uncertain": false, "evidence_type": "explicit_surface", "start_char": 23, "end_char": 33 } ]
[]
1
oncology_consult
ONCORX-0101
Darolutamide initiated per protocol.
C1_CORE_MED_EXTRACTION
C1.1_single_drug_simple
Easy
[ { "drug_surface": "Darolutamide", "drug_normalized": "Darolutamide", "status": "current", "negated": false, "allergy": false, "uncertain": false, "evidence_type": "explicit_surface", "start_char": 0, "end_char": 12 } ]
[]
1
progress_note
ONCORX-0102
Recommend initiation of Ixazomib.
C1_CORE_MED_EXTRACTION
C1.1_single_drug_simple
Easy
[ { "drug_surface": "Ixazomib", "drug_normalized": "Ixazomib", "status": "current", "negated": false, "allergy": false, "uncertain": false, "evidence_type": "explicit_surface", "start_char": 24, "end_char": 32 } ]
[]
1
treatment_plan
ONCORX-0104
Olaparib initiated per protocol.
C1_CORE_MED_EXTRACTION
C1.1_single_drug_simple
Easy
[ { "drug_surface": "Olaparib", "drug_normalized": "Olaparib", "status": "current", "negated": false, "allergy": false, "uncertain": false, "evidence_type": "explicit_surface", "start_char": 0, "end_char": 8 } ]
[]
1
progress_note
ONCORX-0105
Cemiplimab initiated per protocol.
C1_CORE_MED_EXTRACTION
C1.1_single_drug_simple
Easy
[ { "drug_surface": "Cemiplimab", "drug_normalized": "Cemiplimab", "status": "current", "negated": false, "allergy": false, "uncertain": false, "evidence_type": "explicit_surface", "start_char": 0, "end_char": 10 } ]
[]
1
oncology_consult
ONCORX-0106
The patient was started on Bleomycin.
C1_CORE_MED_EXTRACTION
C1.1_single_drug_simple
Easy
[ { "drug_surface": "Bleomycin", "drug_normalized": "Bleomycin", "status": "current", "negated": false, "allergy": false, "uncertain": false, "evidence_type": "explicit_surface", "start_char": 27, "end_char": 36 } ]
[]
1
progress_note
ONCORX-0107
Treatment: Apalutamide.
C1_CORE_MED_EXTRACTION
C1.1_single_drug_simple
Easy
[ { "drug_surface": "Apalutamide", "drug_normalized": "Apalutamide", "status": "current", "negated": false, "allergy": false, "uncertain": false, "evidence_type": "explicit_surface", "start_char": 11, "end_char": 22 } ]
[]
1
oncology_consult
ONCORX-0108
Treatment: Trametinib.
C1_CORE_MED_EXTRACTION
C1.1_single_drug_simple
Easy
[ { "drug_surface": "Trametinib", "drug_normalized": "Trametinib", "status": "current", "negated": false, "allergy": false, "uncertain": false, "evidence_type": "explicit_surface", "start_char": 11, "end_char": 21 } ]
[]
1
oncology_consult
ONCORX-0109
Patient has been on Elotuzumab since last visit.
C1_CORE_MED_EXTRACTION
C1.1_single_drug_simple
Easy
[ { "drug_surface": "Elotuzumab", "drug_normalized": "Elotuzumab", "status": "current", "negated": false, "allergy": false, "uncertain": false, "evidence_type": "explicit_surface", "start_char": 20, "end_char": 30 } ]
[]
1
progress_note
ONCORX-0110
Home medications include Tamoxifen.
C1_CORE_MED_EXTRACTION
C1.1_single_drug_simple
Easy
[ { "drug_surface": "Tamoxifen", "drug_normalized": "Tamoxifen", "status": "current", "negated": false, "allergy": false, "uncertain": false, "evidence_type": "explicit_surface", "start_char": 25, "end_char": 34 } ]
[]
1
treatment_plan
ONCORX-0111
Continue Fluorouracil as previously prescribed.
C1_CORE_MED_EXTRACTION
C1.1_single_drug_simple
Easy
[ { "drug_surface": "Fluorouracil", "drug_normalized": "Fluorouracil", "status": "current", "negated": false, "allergy": false, "uncertain": false, "evidence_type": "explicit_surface", "start_char": 9, "end_char": 21 } ]
[]
1
oncology_consult
ONCORX-0112
Assessment/Plan: Degarelix for treatment.
C1_CORE_MED_EXTRACTION
C1.1_single_drug_simple
Easy
[ { "drug_surface": "Degarelix", "drug_normalized": "Degarelix", "status": "current", "negated": false, "allergy": false, "uncertain": false, "evidence_type": "explicit_surface", "start_char": 17, "end_char": 26 } ]
[]
1
progress_note
ONCORX-0114
Medications: Carfilzomib.
C1_CORE_MED_EXTRACTION
C1.1_single_drug_simple
Easy
[ { "drug_surface": "Carfilzomib", "drug_normalized": "Carfilzomib", "status": "current", "negated": false, "allergy": false, "uncertain": false, "evidence_type": "explicit_surface", "start_char": 13, "end_char": 24 } ]
[]
1
progress_note
ONCORX-0115
Trametinib was administered during today's visit.
C1_CORE_MED_EXTRACTION
C1.1_single_drug_simple
Easy
[ { "drug_surface": "Trametinib", "drug_normalized": "Trametinib", "status": "current", "negated": false, "allergy": false, "uncertain": false, "evidence_type": "explicit_surface", "start_char": 0, "end_char": 10 } ]
[]
1
oncology_consult
ONCORX-0116
Patient reports taking Axitinib at home.
C1_CORE_MED_EXTRACTION
C1.1_single_drug_simple
Easy
[ { "drug_surface": "Axitinib", "drug_normalized": "Axitinib", "status": "current", "negated": false, "allergy": false, "uncertain": false, "evidence_type": "explicit_surface", "start_char": 23, "end_char": 31 } ]
[]
1
progress_note
ONCORX-0117
Initiate therapy with Sorafenib as discussed.
C1_CORE_MED_EXTRACTION
C1.1_single_drug_simple
Easy
[ { "drug_surface": "Sorafenib", "drug_normalized": "Sorafenib", "status": "current", "negated": false, "allergy": false, "uncertain": false, "evidence_type": "explicit_surface", "start_char": 22, "end_char": 31 } ]
[]
1
treatment_plan
ONCORX-0119
The patient is scheduled to receive Bendamustine.
C1_CORE_MED_EXTRACTION
C1.1_single_drug_simple
Easy
[ { "drug_surface": "Bendamustine", "drug_normalized": "Bendamustine", "status": "current", "negated": false, "allergy": false, "uncertain": false, "evidence_type": "explicit_surface", "start_char": 36, "end_char": 48 } ]
[]
1
progress_note
ONCORX-0120
Treatment: Etoposide.
C1_CORE_MED_EXTRACTION
C1.1_single_drug_simple
Easy
[ { "drug_surface": "Etoposide", "drug_normalized": "Etoposide", "status": "current", "negated": false, "allergy": false, "uncertain": false, "evidence_type": "explicit_surface", "start_char": 11, "end_char": 20 } ]
[]
1
oncology_consult
ONCORX-0122
Continue Methylprednisolone as previously prescribed.
C1_CORE_MED_EXTRACTION
C1.1_single_drug_simple
Easy
[ { "drug_surface": "Methylprednisolone", "drug_normalized": "Methylprednisolone", "status": "current", "negated": false, "allergy": false, "uncertain": false, "evidence_type": "explicit_surface", "start_char": 9, "end_char": 27 } ]
[]
1
progress_note
ONCORX-0124
The patient is scheduled to receive Procarbazine.
C1_CORE_MED_EXTRACTION
C1.1_single_drug_simple
Easy
[ { "drug_surface": "Procarbazine", "drug_normalized": "Procarbazine", "status": "current", "negated": false, "allergy": false, "uncertain": false, "evidence_type": "explicit_surface", "start_char": 36, "end_char": 48 } ]
[]
1
oncology_consult
ONCORX-0125
Treatment: Thioguanine.
C1_CORE_MED_EXTRACTION
C1.1_single_drug_simple
Easy
[ { "drug_surface": "Thioguanine", "drug_normalized": "Thioguanine", "status": "current", "negated": false, "allergy": false, "uncertain": false, "evidence_type": "explicit_surface", "start_char": 11, "end_char": 22 } ]
[]
1
treatment_plan
ONCORX-0126
Initiate therapy with Degarelix as discussed.
C1_CORE_MED_EXTRACTION
C1.1_single_drug_simple
Easy
[ { "drug_surface": "Degarelix", "drug_normalized": "Degarelix", "status": "current", "negated": false, "allergy": false, "uncertain": false, "evidence_type": "explicit_surface", "start_char": 22, "end_char": 31 } ]
[]
1
treatment_plan
ONCORX-0127
Active medication: Apalutamide.
C1_CORE_MED_EXTRACTION
C1.1_single_drug_simple
Easy
[ { "drug_surface": "Apalutamide", "drug_normalized": "Apalutamide", "status": "current", "negated": false, "allergy": false, "uncertain": false, "evidence_type": "explicit_surface", "start_char": 19, "end_char": 30 } ]
[]
1
oncology_consult
End of preview. Expand in Data Studio

OncoRx-Bench

OncoRx-Bench is a controlled synthetic dataset for research on medication and oncology-regimen information extraction. The reference release contains 2,000 automatically generated records: 1,600 training rows and 400 test rows. Whole source-template groups are assigned to one split, yielding zero source-template overlap while preserving an exact 80/20 split within every subcategory.

The text and task-selected annotations are synthetic. Automated validation establishes structural, referential, offset, evidence, distribution, and split consistency; it does not establish clinical validity. The dataset is not for clinical use, clinical decision-making, prescribing, or patient care.

Links

Data files

Split Path Rows
train data/train.jsonl 1,600
test data/test.jsonl 400

The split union contains exactly ONCORX-0001 through ONCORX-2000, with no duplicate identifiers and no overlap. The canonical full JSONL SHA-256 is 97a6c2a22eacf0d68e1762051fbe57b943f24c032a014eadd64f7e36aecf952f.

from datasets import load_dataset

dataset = load_dataset("AbhishekShivanna/oncorx-bench")
print(dataset["train"][0])

Schema

Field Type Description
sample_id string Record identifier
clinical_text string Synthetic input text
category string Major evaluation category
subcategory string Fine-grained evaluation category
difficulty string Author-assigned scenario difficulty
drug_mentions list of objects Drug evidence spans, normalized labels, context, and optional prescribing attributes
regimen_mentions list of objects Regimen evidence spans, normalized labels, projected components, and visible cycle/intent metadata
num_drugs integer Number of unique normalized drugs in drug_mentions
note_type string Scenario-conditioned synthetic note-type metadata

Drug objects include inclusive start_char and exclusive end_char offsets. The evidence_type field distinguishes a literal explicit_surface from a regimen_inference, for which the stored evidence span is the named regimen. Optional fields are omitted when they are not supported by the rendered text.

Reference-release composition

  • 3,525 drug annotation objects, including 2,974 explicit-surface objects and 551 regimen-inference objects
  • 170 unique normalized drugs and 433 stored evidence surfaces: 328 literal drug surfaces and 105 regimen-evidence spans
  • 1,286 drug objects with prescribing information
  • 444 regimen objects spanning 176 normalized regimen names
  • 1,110 component assignments spanning 109 unique components
Category Description Rows
C1 Core medication extraction 600
C2 Prescribing information 450
C3 Regimen semantics 450
C4 Context and safety language 300
C5 Noise and ambiguity 200

Provenance and reproducibility

The generator consumes three checked-in benchmark views derived by a checksum-verifying adapter from a pinned Unified Oncology Treatment Database revision. The source repository contains the materialized inputs, projection audit, provenance manifest, generator, strict validator, deterministic split exporter, tests, and one-command byte-comparison workflow.

This Hugging Face repository intentionally contains only the dataset card and Viewer-compatible split files. Benchmark generation and validation code lives in the linked GitHub repository.

Limitations

  • Records are short English template-generated snippets, not real clinical notes, and they do not model full documents or EHR prevalence.
  • No independent clinical adjudication was performed. Knowledge grounding and structural validation do not prove the appropriateness of every disease, drug, dose, route, frequency, schedule, or regimen combination.
  • Annotations are task-selected rather than guaranteed exhaustive for every medication-like string in every category.
  • The provided split is source-template-disjoint but not drug-, entity-, or regimen-disjoint.
  • Author-controlled attribute profiles and surface-variation maps are synthetic benchmark controls, not treatment recommendations.

License and redistribution

No license is declared for this dataset release. Public availability does not supersede the terms of the source knowledge resources. Review the data notice and provenance in the linked GitHub repository before redistribution or commercial use.

Citation

Until the paper is published, cite this dataset repository and the exact Hub revision used. Use the linked GitHub repository for the corresponding source revision and reproduction instructions.

Downloads last month
17